Please assess the completion status of the following clinical trial:

Trial Title: Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Healthy adults 30 - 70 years old~2. BMI: 20 - 37 kg/m2~3. Without diabetes as defined by fasting plasma glucose \<126 mg/dL and not taking glucose lowering medications~4. Eligible for statin therapy for primary prevention of ASCVD based on LDL-C ≥ 130 mg/dL, \> 5% ASCVD risk over 10 years, or hs-CRP ≥ 2.0 mg/L~Exclusion Criteria:~1. Younger than 30 or older than 70 years~2. Persons with any significant co-morbidities, such as diabetes (fasting glucose ≥ 126 mg/dL or use of glucose lowering medications), active coronary artery disease, heart failure, accelerated or malignant hypertension, kidney disease (creatinine ≥ 1.5 mg/dL), liver disease (alanine aminotransferase \> 2 times upper limit of normal), or severe anemia (hematocrit \< 30%).~3. Individuals taking any medications for weight loss or known to influence insulin sensitivity.~4. Pregnant or lactating~5. Women unwilling to use an effective birth control method~6. History of statin intolerance

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Individuals without diabetes eligible to receive statin therapy (Type: OTHER): Eligible participants will receive 40 mg of atorvastatin

Based on this trial design, predict the completion outcome and termination type (if applicable).